Skip to content
  • Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Policies
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
    • News archive
Homepage
Open navigation
  • Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Policies
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
    • News archive

Posts in: talent

CSO Tyler Korman - and Chief of Staff, Amy Lunzer
talentpress releaseinvestor
eXoZymes announces cell-free biomanufacturing pioneer, Tyler Korman, as CSO & Amy Lunzer as Chief of StaffNovember 13, 2025
CSO, Tyler Korman
talentinvestorvideo
Co-founder of eXoZymes and cell-free biomanufacturing pioneer, Tyler Korman, speaks to his new role as CSONovember 13, 2025
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
talentpress releaseinvestorvideo
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCOApril 2, 2025
ARCHIVE: Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
talentpress releaseARCHIVE
ARCHIVE: Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on NasdaqMay 7, 2024
ARCHIVE: Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
talentbiofuelARCHIVE
ARCHIVE: Michael Burns Joins Invizyne as Executive Vice President of Energy TransitionNovember 8, 2023

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

logo mark